GPN vs MBX · P/E 24, rev $6.29B vs $1.98B cap
Global Payments Inc (GPN) versus MBX Biosciences, Inc. Common Stock (MBX) — a side-by-side from cached financials, not a winner call.
Global Payments Inc (GPN) is a specialty business services company listed on US.
MBX Biosciences, Inc. Common Stock (MBX) is a biotechnology company listed on NASDAQ.
Latest reported GPN revenue for 2026-06-30 was $6.29B. Net income was -$1.79B. GPN currently screens at market cap $18.14B and trailing P/E 24.4.
MBX does not have a complete income-statement cache yet.
GPN currently screens at market cap $18.14B and trailing P/E 24.4. MBX currently screens at market cap $1.98B.
Not investment advice. Open the GPN and MBX stock pages for the full models.
Not investment advice.